The Yellow Card Scheme: why your report matters

Ask most people what a “yellow card” is and they’ll picture a referee penalising a questionable tackle. In the healthcare industry, however, the Yellow Card Scheme is something very different: a national system for collecting reports about adverse reactions to medicines, vaccines and medical devices, helping to keep them safe.1

How Numan's support unlocked new experiences for Ana on holiday

For Ana, working with Numan has been about unlocking the confidence to live fully. It's not just about numbers on a scale but about saying yes to new experiences. Her recent holiday perfectly captures this shift.

Two Pints, one doctor, and a blood test: Dr Dave joins Will and Ralf

When you tune into Two Pints with Will and Ralf, you know what you’re getting. A little chaos, a lot of laughter, and the kind of banter that makes you feel like you’re eavesdropping on old mates. Season six kicked off in a new studio with a fresh backdrop but the same laddish chemistry. Within minutes they were joking about their knobs, “scrotox” (yes, Botox for balls), and the physics of testicle temperature.

Is AI closing the gender health gap - or making it worse?

On one side lies the promise of revolutionary tools that could finally address centuries of gender-based healthcare disparities. On the other, the risk that these same tools might unknowingly amplify the very inequities they aim to solve.

What do patients actually want AI to do for their health?

The rise of AI in healthcare has opened the door to extraordinary possibilities around personalised support, getting you to the right care faster, and systems that learn with every interaction. However, it has also revealed real risks, not always the kind that make headlines.

Can AI ease clinical burnout and boost productivity?

Artificial intelligence is sold as the cure for clinician burnout, promising to slash admin and free up doctors to focus on patients. But this narrative misses the point. The real power of AI isn’t in speeding up tasks – it’s in forcing a fundamental rethink of how we train, value, and support our healthcare professionals.

Safety isn’t a feature - it’s the foundation of AI in healthcare

The rise of AI in healthcare has opened the door to extraordinary possibilities around personalised support, getting you to the right care faster, and systems that learn with every interaction. However, it has also revealed real risks, not always the kind that make headlines.

Two Pints with Will and Ralf: where banter meets men’s health

There’s something reassuringly familiar about hearing Will Mellor and Ralf Little in full flow. For many, they’ll always be Gaz and Jonny from Two Pints of Lager and a Packet of Crisps. But over the last few years, the pair have built a new stage for themselves: Two Pints with Will & Ralf, a podcast that mixes comedy, friendship, and the sort of unfiltered conversation you’d expect after ‘two pints’ in the pub.

What is AMH? Understanding your egg reserve biomarker

One of the most useful hormone health biomarkers for women to test is Anti-Müllerian Hormone (AMH). AMH is produced by the follicles in your ovaries and indicates how many eggs you have left. Testing your AMH levels won’t give you the full picture of your reproductive health, but it can bring some clarity where there’s confusion and a sense of direction where there’s doubt.

New price changes for Mounjaro – what they are, why they happened, and what the options are

We know price rises are the last thing you want to deal with when you’re working hard on your health. This update explains what’s changing, why it’s happening, and your options if you’re on treatment or thinking about starting.

Confused by Wegovy switching claims? Here’s what the evidence really says

With fast‑moving (and sometimes conflicting) claims about Wegovy, it can be hard to know what to trust when you’re considering a switch. A lot of the confusion comes from mixing up doses, brands, timelines, and UK‑specific rules.

How to get Wegovy on the NHS

Wegovy (semaglutide) is a once-weekly injection that helps regulate appetite, slow digestion, and support weight loss when combined with healthy lifestyle changes. But while it’s gaining popularity, getting Wegovy on the NHS isn’t as straightforward as asking your GP for a prescription.

Your first month on Wegovy after Mounjaro: what to expect

Switching from one weight loss medication to another can feel daunting, especially if you’ve worked hard to make progress on Mounjaro. Many people worry that moving to Wegovy will undo their results or set them “back to square one.” However, with the right plan and support, you can protect your progress and keep building on the hard work you’ve already put in.

Top 5 myths about switching from Mounjaro to Wegovy

If you’ve been reading the news lately, you’ll know that switching from Mounjaro to Wegovy has sparked a lot of discussion. Some people are worried about side effects, others are anxious about losing progress, and plenty of myths are flying around about how the switch works.

How to stay on track during your switch from Mounjaro to Wegovy

Switching from one weight loss medication to another can feel a bit daunting. If you’re moving from Mounjaro to Wegovy, you might worry about setbacks, side effects, or whether your progress will stall.

The science behind switching: why some people might respond better to different weight loss medications

Weight loss treatments have transformed the way we treat obesity. Clinical trials show that people using these medications can lose anywhere between 16% and 21% of their body weight, depending on the drug and how well they stick with treatment.1,2 For many, that’s life-changing progress which leads to less breathlessness when walking upstairs, clothes that fit more comfortably, and improved health markers like blood pressure or blood sugar.1-3

Switching from Mounjaro to Wegovy: expert advice from a Numan doctor

As you may be aware, Eli Lilly has announced a UK price increase on Mounjaro. We know changes like this can be unsettling. Our priority is safe, continuous care - keeping you informed, helping you weigh up your options, and supporting whatever decision you make.

Worried about Mounjaro price changes? Here’s what you need to know

From September, UK patients paying privately for Mounjaro - the weekly tirzepatide injection - will see significant price hikes, with some doses more than doubling.